Abstract

An exploratory field trial in grass allergic subjects was conducted using PQ Grass, a modified grass allergen subcutaneous immunotherapy in combination with an adjuvant system of Microcrystalline Tyrosine and Monophosphoryl Lipid A. Changes in immunomodulatory profile of PQ Grass were explored via transcriptome analysis of peripheral blood from eligible subjects.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call